Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Families In Recovery From Stroke Trial (F.I.R.S.T.)
This study has been completed.
Sponsored by: National Institute of Neurological Disorders and Stroke (NINDS)
Information provided by: National Institute of Neurological Disorders and Stroke (NINDS)
ClinicalTrials.gov Identifier: NCT00037492
  Purpose

The purpose of this trial is to assess the effects of a psychosocial intervention on functional recovery after stroke.


Condition Intervention Phase
Stroke
Procedure: home-based sessions/family meetings with trained clinician
Phase III

U.S. FDA Resources
Study Type: Interventional
Study Design: Prevention, Randomized
Official Title: Psychological Intervention in Stroke Recovery

Further study details as provided by National Institute of Neurological Disorders and Stroke (NINDS):

Estimated Enrollment: 291
Detailed Description:

Prior research shows that, after a stroke, emotional support from friends and family is very important in recovery from stroke. This study was designed to test whether a program of family sessions would lead to a faster recovery for stroke patients and lower stress for their families. The sessions were designed to mobilize the family and close friends of a stroke patient and help them to provide effective support to the patient. The aim of the study was to help patients who have recently had a stroke to achieve greater functional ability. Participants were randomly assigned to either the standard care or the treatment group. Those in the treatment group received standard care plus a maximum of 16 home-based sessions, or family meetings, with a specially-trained clinician. (The majority of participants received 14 or 15 sessions.) The sessions included stroke education, information about services and community resources, assistance with problem solving to aid in gaining independence, help with coping, and emotional support. The study is no longer enrolling patients and the study data has been collected. The data is now being analyzed.

  Eligibility

Ages Eligible for Study:   45 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion:

  • patients with ischemic stroke or non-traumatic intracerebral hemorrhage, with residual deficit origin;
  • age 45 or older
  • stroke severity (3-8 on the NIH stroke severity scale); and
  • able to participate in the intervention (due to, for example, ability to communicate or level of social connectedness).

Exclusion:

  • patients living outside the greater Boston area;
  • admitted from a nursing home;
  • terminally ill;
  • severely aphasic;
  • significantly cognitively impaired;
  • unable to speak English; and
  • under 45 years of age.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00037492

Locations
United States, Massachusetts
Massachusetts General Hospital
Boston, Massachusetts, United States, 02114
Brigham and Women’s Hospital
Boston, Massachusetts, United States, 02115
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States, 02215
Youville Rehabilitation Hospital
Cambridge, Massachusetts, United States, 02138
Spaulding Rehabilitation Hospital
Boston, Massachusetts, United States, 02114
Mount Auburn Hospital
Cambridge, Massachusetts, United States, 02238
Sponsors and Collaborators
Investigators
Principal Investigator: Lisa Berkman, PhD Harvard School of Public Health, Department of Society, Human Development, and Health
  More Information

Study ID Numbers: R01NS32324
Study First Received: May 17, 2002
Last Updated: May 21, 2007
ClinicalTrials.gov Identifier: NCT00037492  
Health Authority: United States: Federal Government

Keywords provided by National Institute of Neurological Disorders and Stroke (NINDS):
stroke
recovery

Study placed in the following topic categories:
Cerebral Infarction
Stroke
Vascular Diseases
Brain Ischemia
Central Nervous System Diseases
Ischemia
Brain Infarction
Brain Diseases
Infarction
Cerebrovascular Disorders

Additional relevant MeSH terms:
Nervous System Diseases
Cardiovascular Diseases

ClinicalTrials.gov processed this record on January 16, 2009